June 18th 2025
Early circulating tumor DNA (ctDNA) changes predict survival in mismatch repair or microsatellite instability–high (dMMR/MSI-H) metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICIs).
OS Disparity, Driver Gene Variations by Race and Ethnicity Seen in CRC
Updated Colonoscopy Guidelines Have Implications on Doctors, Patients Alike